Home LiteratureArticle Details
PMID: 7650010 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Rapid and persistent desensitization of m3 muscarinic acetylcholine receptor-stimulated phospholipase D. Concomitant sensitization of phospholipase C.

The Journal of biological chemistry ·Vol. 270 ·No. 34 ·1995-08-25 ·Pages 19949-56

Schmidt M, Fasselt B, Rümenapp U, Bienek C, Wieland T, van Koppen CJ, Jakobs KH

Abstract

Activation of muscarinic acetylcholine receptors (mAChR) in human embryonic kidney (HEK) cells stably expressing the human m3 subtype leads to stimulation of both phospholipase C (PLC) and D (PLD). mAChR-stimulated PLD was turned off after 2 min of receptor activation with either the full (carbachol) or partial agonist (pilocarpine) and remained completely suppressed for at least 4 h. Partial recovery was observed 24 h after agonist removal. This rapid arrest of PLD response was not due to a loss of cell surface receptors and was also not caused by negative feedback due to concomitant activation of protein kinase C, tyrosine phosphorylation, increase in cytosolic calcium, or activation of Gi proteins. Furthermore, PLD stimulation by directly activated protein kinase C and GTP-binding proteins was unaltered in carbachol-pretreated cells. Finally, neither prevention of PLD stimulation during carbachol pretreatment by genistein nor inhibition of protein synthesis by cycloheximide, added before or after carbachol challenge, resulted in recovery of mAChR-stimulated PLD. The short term carbachol pretreatment nearly completely abolished agonist-induced binding of guanosine 5'-O-(3-thiotriphosphate) to membranes or permeabilized adherent cells. Full recovery of this response was achieved after 4 h. Similar to transfected m3 mAChR, PLD stimulation by endogenously expressed purinergic receptors was also fully blunted after 2 min of agonist (ATP) treatment. Preexposure of HEK cells to either receptor agonist partially, but not completely, reduced PLD stimulation by the other agonist. In contrast to desensitization of PLD stimulation, 2 min of carbachol treatment led to a sensitization, by up to 2-fold, of mAChR-stimulated inositol phosphate formation. This supersensitivity was also observed with pilocarpine, which acted as a full agonist on PLC. On the basis of these results, we conclude that the m3 mAChR stimulates PLD and PLC in HEK cells with distinct efficiencies and with very distinct durations of each response. The rapid and long lasting desensitization of the PLD response is apparently not due to a loss of cell surface receptors or PLD activation by GTP-binding proteins, but it may involve, at least initially, an uncoupling of receptors from GTP-binding proteins and most likely a loss of an as yet undefined essential transducing component.

MeSH Terms
Carbachol/pharmacology Cell Line Enzyme Activation/drug effects GTP-Binding Proteins/metabolism Guanosine 5'-O-(3-Thiotriphosphate)/metabolism Humans Kinetics Muscarinic Agonists Phospholipase D/metabolism Pilocarpine/pharmacology Receptors, Muscarinic/genetics,metabolism Receptors, Purinergic/metabolism Transfection Type C Phospholipases/metabolism
Chemicals
Muscarinic Agonists Receptors, Muscarinic Receptors, Purinergic Pilocarpine Guanosine 5'-O-(3-Thiotriphosphate) Carbachol Type C Phospholipases Phospholipase D GTP-Binding Proteins
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Schmidt M
Institut für Pharmakologie, Universität GH Essen, Germany.
Fasselt B
Rümenapp U
Bienek C
Wieland T
van Koppen C J
Jakobs K H
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
1995-08-25
Pages
19949-56
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]